FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1144477009: Relugolix (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4542089017 Relugolix (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4542090014 Relugolix en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Relugolix (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadotropin releasing hormone receptor antagonist (disposition) true Inferred relationship Some
Relugolix (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Relugolix (substance) Is a Gonadotropin releasing hormone receptor antagonist true Inferred relationship Some
Relugolix (substance) Is a Substance with benzene structure true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Relugolix-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix (substance) Inferred relationship Some 1
Product containing only relugolix (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix (substance) Inferred relationship Some 1
Product containing relugolix in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix (substance) Inferred relationship Some 1
Product containing only relugolix in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Relugolix (substance) Inferred relationship Some 1
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Relugolix (substance) Inferred relationship Some 1
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Relugolix (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start